Center-Authored Papers

Filters: Keyword is DENDRITIC CELLS  [Clear All Filters]
A
Anderson LD, Cook DR, Yamamoto TN, Berger C, Maloney DG, Riddell SR.  2011.  Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.. Cancer immunology, immunotherapy : CII. 60(7):985-97. Abstract
B
Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin H-S, Brooks SF, Knight HL, Eichbaum Q et al..  2009.  Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.. Journal of virology. 83(14):7305-21. Abstract
C
Cheever MA.  2008.  Twelve immunotherapy drugs that could cure cancers.. Immunological reviews. 222:357-68. Abstract
Corbett NP, Blimkie D, Ho KC, Cai B, Sutherland DP, Kallos A, Crabtree J, Rein-Weston A, Lavoie PM, Turvey SE et al..  2010.  Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells.. PloS one. 5(11):e15041. Abstract
E
Eisenbarth SC, Williams A, Colegio OR, Meng H, Strowig T, Rongvaux A, Henao-Mejia J, Thaiss CA, Joly S, Gonzalez DG et al..  2012.  NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells.. Nature. 484(7395):510-3. Abstract
von Euw EM, Barrio MM, Furman D, Levy EM, Bianchini M, Peguillet I, Lantz O, Vellice A, Kohan A, Chacón M et al..  2008.  A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of diseas. Journal of translational medicine. 6:6. Abstract
G
Greenberg PD.  2011.  Ralph M. Steinman: A man, a microscope, a cell, and so much more.. Proceedings of the National Academy of Sciences of the United States of America. 108(52):20871-2.
K
Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, Wang XY, Lavoie PM, Furlong J, Fortuno ES, Hajjar AM et al..  2009.  Neonatal innate TLR-mediated responses are distinct from those of adults.. Journal of immunology (Baltimore, Md. : 1950). 183(11):7150-60. Abstract
L
Lemke CD, Graham JB, Geary SM, Zamba G, Lubaroff DM, Salem AK.  2011.  Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.. Molecular pharmaceutics. 8(5):1652-61. Abstract
Liao X, Li Y, Bonini C, Nair S, Gilboa E, Greenberg PD, Yee C.  2004.  Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(5):757-64. Abstract
Lindsay RWB, Darrah PA, Quinn KM, Wille-Reece U, Mattei LM, Iwasaki A, Kasturi SP, Pulendran B, Gall JGD, Spies GA et al..  2010.  CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.. Journal of immunology (Baltimore, Md. : 1950). 185(3):1513-21. Abstract
M
Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, López-Botet M.  2011.  NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.. Blood. 117(3):848-56. Abstract
Mielcarek M, Kucera KA, Nash R, Torok-Storb B, McKenna HJ.  2007.  Identification and characterization of canine dendritic cells generated in vivo.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(11):1286-93. Abstract
N
Nakamae H, Storer BE, Storb R, Storek J, Chauncey TR, Pulsipher MA, Petersen FB, Wade JC, Maris MB, Bruno B et al..  2010.  Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(3):384-94. Abstract
P
Palmer LA, Sale GE, Balogun JI, Li D, Jones D, Molldrem JJ, Storb R, Ma Q.  2010.  Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(3):311-9. Abstract
Peng T, Zhu J, Klock A, Phasouk K, Huang M-L, Koelle DM, Wald A, Corey L.  2009.  Evasion of the mucosal innate immune system by herpes simplex virus type 2.. Journal of virology. 83(23):12559-68. Abstract
Pufnock JS, Cigal M, Rolczynski LS, Andersen-Nissen E, Wolfl M, McElrath MJ, Greenberg PD.  2011.  Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.. Blood. 117(24):6542-51. Abstract
Q
Quakkelaar ED, Redeker A, Haddad EK, Harari A, McCaughey SM, Duhen T, Filali-Mouhim A, Goulet J-P, Loof NM, Ossendorp F et al..  2011.  Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors.. PloS one. 6(2):e16819. Abstract
S
Sabado RL, O'Brien M, Subedi A, Qin L, Hu N, Taylor E, Dibben O, Stacey A, Fellay J, Shianna KV et al..  2010.  Evidence of dysregulation of dendritic cells in primary HIV infection.. Blood. 116(19):3839-52. Abstract
Stroncek D, Berlyne D, Fox B, Gee A, Heimfeld S, Lindblad R, Loper K, McKenna D, Rooney C, Sabatino M et al..  2010.  Developments in clinical cell therapy.. Cytotherapy. 12(3):425-8. Abstract
Suthar MS, Ramos HJ, Brassil MM, Netland J, Chappell CP, Blahnik G, McMillan A, Diamond MS, Clark EA, Bevan MJ et al..  2012.  The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness.. Immunity. 37(2):235-48. Abstract